Crescent

Women's Health Continuum

The governance layer women's health now has.

Confidential · May 2026

Woman in clinical setting

"She sees five specialists.
Nobody sees her."

Five specialists. Four EMR systems. Three years. One woman's journey through fertility, pregnancy, autoimmune, and GI care — with nobody holding the thread.

84% of maternal deaths are preventable. (CDC MMRC)

$7.00

per female member per month in uncoordinated complexity

$8.4M annual waste per 100K-member book

Downstream claims, redundant testing, preventable admissions, and missed interventions across every sex-linked condition.

Modeled from CDC, NCHS, and AARDA prevalence data

Maternity Complications
Preventable C-sections, readmissions $2.10
Autoimmune / GI Flares
ER visits, unmanaged exacerbations $2.65
Postpartum BH + Coordination Gaps
Missed screens, fragmented follow-up $1.20
Pharmacy + Lab Waste
Duplicate labs, unoptimized Rx $1.05
Total $7.00

What Crescent Does

Crescent sits between the payer and the women's health delivery system.

We review utilization, flag coordination failures, enforce clinical protocols, and manage transitions across every sex-linked condition — fertility through menopause.

One layer. Seven modules. No member app required.

Crescent ingests claims data, clinical flags, and utilization metrics — no EHR integration required.

Seven Modules. One Continuum.

Foundation
Intake & Stratification
Acute
Fertility Management
Maternity & OB/GYN Governance
Postpartum Behavioral Health
Chronic
Autoimmune & GI
Pharmacy & Lab Optimization
Continuous
Care Navigation & Steering

Point solutions address symptoms. Crescent governs the architecture.

Fertility Maternity Autoimmune GI Rx Labs Nav
Maven • • •
Progyny • •
Pomelo • •
Visana • •
Crescent • • • • • • •

Maven: $1.7B. Progyny: $1.29B revenue. Pomelo: $92M raised. None governs the full continuum.

Crescent is the only company in this table that governs the full arc.

The Economics

NICU avoidance$2,520,000
Autoimmune flare$3,200,000
C-section reduction$176,000
Biosimilar conversion$1,400,000
GI site-of-care$680,000
Lab optimization$424,000
Total$8,400,000

Largest lever: autoimmune flare management — 38% of total savings.

Fee $1.50 – $3.00 PMPM
ROI 2.3x – 4.7x

Performance guarantee: if Year 1 savings don't exceed fees, Year 2 is free.

Annual subscription. Per-member-per-month pricing. Modular — start with maternity, expand to the full continuum.

Revenue Trajectory

$1.1M
Year 1
$8.2M
Year 2
$37.8M
Year 3
$78.5M
Year 4
$125.4M
Year 5

Cash-flow positive by Q3 of Year 2.

Capital accelerates the timeline. The model works without it.

Go-to-Market

Phase 1: Employer Direct + TPA Channel
First Revenue · Months 1–12
Target: self-funded employers, 25K–100K lives. Maternity and fertility modules first.
Phase 2: Regional Health Plans
Scale Revenue · Months 6–18
Leveraging employer outcomes data as proof points.
Phase 3: Medicaid MCOs + National Plans
Structural Revenue · Months 12–36
Aligned to CMS maternal health mandates and HEDIS measures.

Conversations begin across all channels from Day 1.

The Team

Specialty risk executive with a senior product role on the payer side, focused on specialty risk.

Prior governance methodology applied across 65,234 specialty pharmacy patients established the approach Crescent extends to women's health.

Part of the Corridor family: Cadence (specialty governance), Curated (episode-based care), Caliber (claims verification), Covenant (delegation oversight).

We're looking for founding partners.

One self-funded employer (25,000–100,000 lives) willing to pilot the full model.
One TPA partner with an existing employer book expressing demand for women's health management.
One regional health plan willing to run a 12-month pilot.

Pilot cohort: Q3 2026 · 45 days to implement · No integration required

Floor-rate pricing. Direct founder access. Full-fee-at-risk guarantee.

joe.nalley@showyourwork.health

30-minute walkthrough available. I'll bring the numbers for your book.